
Gary Jackson
Supervisory Patent Examiner (ID: 5661, Phone: (571)272-4697 , Office: P/3769 )
| Most Active Art Unit | 3731 |
| Art Unit(s) | 3304, 3308, 4158, 3727, 3309, 2899, 3734, 3792, 3731, 3407, 3769 |
| Total Applications | 2094 |
| Issued Applications | 1632 |
| Pending Applications | 166 |
| Abandoned Applications | 295 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 281640
[patent_doc_number] => 07553639
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-30
[patent_title] => 'Alpha-synuclein kinase'
[patent_app_type] => utility
[patent_app_number] => 11/669093
[patent_app_country] => US
[patent_app_date] => 2007-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 20
[patent_no_of_words] => 22250
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/553/07553639.pdf
[firstpage_image] =>[orig_patent_app_number] => 11669093
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/669093 | Alpha-synuclein kinase | Jan 29, 2007 | Issued |
Array
(
[id] => 296178
[patent_doc_number] => 07541449
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-02
[patent_title] => 'Human kunitz-type inhibitors and methods relating thereto'
[patent_app_type] => utility
[patent_app_number] => 11/619699
[patent_app_country] => US
[patent_app_date] => 2007-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13741
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/541/07541449.pdf
[firstpage_image] =>[orig_patent_app_number] => 11619699
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/619699 | Human kunitz-type inhibitors and methods relating thereto | Jan 3, 2007 | Issued |
Array
(
[id] => 289149
[patent_doc_number] => 07547764
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-16
[patent_title] => 'OrfF and OrfF′ polypeptides, nucleic acid molecules encoding the polypeptides and applications thereof'
[patent_app_type] => utility
[patent_app_number] => 11/649623
[patent_app_country] => US
[patent_app_date] => 2007-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 7332
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/547/07547764.pdf
[firstpage_image] =>[orig_patent_app_number] => 11649623
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/649623 | OrfF and OrfF′ polypeptides, nucleic acid molecules encoding the polypeptides and applications thereof | Jan 3, 2007 | Issued |
Array
(
[id] => 8232368
[patent_doc_number] => 08197808
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-12
[patent_title] => 'Stable enzymatic preparations and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/087108
[patent_app_country] => US
[patent_app_date] => 2006-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 14
[patent_no_of_words] => 10003
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/197/08197808.pdf
[firstpage_image] =>[orig_patent_app_number] => 12087108
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/087108 | Stable enzymatic preparations and methods of use thereof | Dec 26, 2006 | Issued |
Array
(
[id] => 5271137
[patent_doc_number] => 20090074913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'Gene Encoding Protein Responsible for Flocculation Property of Yeast and Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/918496
[patent_app_country] => US
[patent_app_date] => 2006-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8302
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20090074913.pdf
[firstpage_image] =>[orig_patent_app_number] => 11918496
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/918496 | Gene Encoding Protein Responsible for Flocculation Property of Yeast and Use Thereof | Dec 26, 2006 | Abandoned |
Array
(
[id] => 7977571
[patent_doc_number] => 08071532
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-06
[patent_title] => 'Use of C1 inhibitor for the prevention of ischemia-reperfusion injury'
[patent_app_type] => utility
[patent_app_number] => 12/158987
[patent_app_country] => US
[patent_app_date] => 2006-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 17
[patent_no_of_words] => 12343
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/071/08071532.pdf
[firstpage_image] =>[orig_patent_app_number] => 12158987
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/158987 | Use of C1 inhibitor for the prevention of ischemia-reperfusion injury | Dec 18, 2006 | Issued |
Array
(
[id] => 221035
[patent_doc_number] => 07608581
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-10-27
[patent_title] => 'Biofunctional, antimicrobial coatings for medical devices'
[patent_app_type] => utility
[patent_app_number] => 11/638973
[patent_app_country] => US
[patent_app_date] => 2006-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11829
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/608/07608581.pdf
[firstpage_image] =>[orig_patent_app_number] => 11638973
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/638973 | Biofunctional, antimicrobial coatings for medical devices | Dec 13, 2006 | Issued |
Array
(
[id] => 236395
[patent_doc_number] => 07595376
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-29
[patent_title] => 'Poly zinc finger proteins with improved linkers'
[patent_app_type] => utility
[patent_app_number] => 11/639363
[patent_app_country] => US
[patent_app_date] => 2006-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 16958
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/595/07595376.pdf
[firstpage_image] =>[orig_patent_app_number] => 11639363
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/639363 | Poly zinc finger proteins with improved linkers | Dec 13, 2006 | Issued |
Array
(
[id] => 5016192
[patent_doc_number] => 20070259401
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-08
[patent_title] => 'ACTIVATABLE RECOMBINANT NEUROTOXINS'
[patent_app_type] => utility
[patent_app_number] => 11/610440
[patent_app_country] => US
[patent_app_date] => 2006-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 15746
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20070259401.pdf
[firstpage_image] =>[orig_patent_app_number] => 11610440
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/610440 | Activatable recombinant neurotoxins | Dec 12, 2006 | Issued |
Array
(
[id] => 7555456
[patent_doc_number] => 08067357
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-29
[patent_title] => 'Annexin derivatives suitable for pretargeting in therapy and diagnosis'
[patent_app_type] => utility
[patent_app_number] => 12/096996
[patent_app_country] => US
[patent_app_date] => 2006-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 2
[patent_no_of_words] => 7020
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/067/08067357.pdf
[firstpage_image] =>[orig_patent_app_number] => 12096996
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/096996 | Annexin derivatives suitable for pretargeting in therapy and diagnosis | Dec 11, 2006 | Issued |
Array
(
[id] => 8543366
[patent_doc_number] => 08318657
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-11-27
[patent_title] => 'Methods and compositions for preventing and/or treating pancreatitis'
[patent_app_type] => utility
[patent_app_number] => 12/095375
[patent_app_country] => US
[patent_app_date] => 2006-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 32
[patent_no_of_words] => 18379
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12095375
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/095375 | Methods and compositions for preventing and/or treating pancreatitis | Nov 30, 2006 | Issued |
Array
(
[id] => 5264531
[patent_doc_number] => 20090117216
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2009-05-07
[patent_title] => 'Composition and use of phyto-percolate for treatment of disease'
[patent_app_type] => utility
[patent_app_number] => 11/606676
[patent_app_country] => US
[patent_app_date] => 2006-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10596
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0117/20090117216.pdf
[firstpage_image] =>[orig_patent_app_number] => 11606676
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/606676 | Composition and use of phyto-percolate for treatment of disease | Nov 29, 2006 | Issued |
Array
(
[id] => 5264531
[patent_doc_number] => 20090117216
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2009-05-07
[patent_title] => 'Composition and use of phyto-percolate for treatment of disease'
[patent_app_type] => utility
[patent_app_number] => 11/606676
[patent_app_country] => US
[patent_app_date] => 2006-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10596
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0117/20090117216.pdf
[firstpage_image] =>[orig_patent_app_number] => 11606676
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/606676 | Composition and use of phyto-percolate for treatment of disease | Nov 29, 2006 | Issued |
Array
(
[id] => 5259637
[patent_doc_number] => 20070213269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-13
[patent_title] => 'ZINC FINGER BINDING DOMAINS FOR TNN'
[patent_app_type] => utility
[patent_app_number] => 11/564141
[patent_app_country] => US
[patent_app_date] => 2006-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 50955
[patent_no_of_claims] => 93
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20070213269.pdf
[firstpage_image] =>[orig_patent_app_number] => 11564141
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/564141 | Zinc finger binding domains for TNN | Nov 27, 2006 | Issued |
Array
(
[id] => 5416002
[patent_doc_number] => 20090041889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-12
[patent_title] => 'Gene Encoding Protein With Vicinal Diketone or Diacetyl-Reducing Activity and Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/918494
[patent_app_country] => US
[patent_app_date] => 2006-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 8297
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20090041889.pdf
[firstpage_image] =>[orig_patent_app_number] => 11918494
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/918494 | Gene Encoding Protein With Vicinal Diketone or Diacetyl-Reducing Activity and Use Thereof | Nov 20, 2006 | Abandoned |
Array
(
[id] => 5570411
[patent_doc_number] => 20090253789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-08
[patent_title] => 'Preventive/Remedy for Arteriosclerotic Disease and Method of Evaluating Therapeutic Procedure'
[patent_app_type] => utility
[patent_app_number] => 12/084754
[patent_app_country] => US
[patent_app_date] => 2006-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8720
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20090253789.pdf
[firstpage_image] =>[orig_patent_app_number] => 12084754
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/084754 | Preventive/Remedy for Arteriosclerotic Disease and Method of Evaluating Therapeutic Procedure | Nov 9, 2006 | Abandoned |
Array
(
[id] => 7545587
[patent_doc_number] => 08053559
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-08
[patent_title] => 'Biodegradable scaffold with ECM material'
[patent_app_type] => utility
[patent_app_number] => 12/083624
[patent_app_country] => US
[patent_app_date] => 2006-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 12
[patent_no_of_words] => 9125
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/053/08053559.pdf
[firstpage_image] =>[orig_patent_app_number] => 12083624
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/083624 | Biodegradable scaffold with ECM material | Oct 25, 2006 | Issued |
Array
(
[id] => 4455546
[patent_doc_number] => 07892790
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-22
[patent_title] => 'Protein expression in rodent cells'
[patent_app_type] => utility
[patent_app_number] => 12/083535
[patent_app_country] => US
[patent_app_date] => 2006-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11103
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/892/07892790.pdf
[firstpage_image] =>[orig_patent_app_number] => 12083535
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/083535 | Protein expression in rodent cells | Oct 25, 2006 | Issued |
Array
(
[id] => 4916202
[patent_doc_number] => 20080096803
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-24
[patent_title] => 'Carboxymethylated cross-linked tetrameric hemoglobin'
[patent_app_type] => utility
[patent_app_number] => 11/586312
[patent_app_country] => US
[patent_app_date] => 2006-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 27525
[patent_no_of_claims] => 77
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20080096803.pdf
[firstpage_image] =>[orig_patent_app_number] => 11586312
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/586312 | Carboxymethylated cross-linked tetrameric hemoglobin | Oct 23, 2006 | Issued |
Array
(
[id] => 566979
[patent_doc_number] => 07462461
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-12-09
[patent_title] => 'Compositions for inhibiting Sema7A and VLA-1 interaction and the methods of using the same'
[patent_app_type] => utility
[patent_app_number] => 11/550184
[patent_app_country] => US
[patent_app_date] => 2006-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5306
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/462/07462461.pdf
[firstpage_image] =>[orig_patent_app_number] => 11550184
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/550184 | Compositions for inhibiting Sema7A and VLA-1 interaction and the methods of using the same | Oct 16, 2006 | Issued |